Skip to main content
. 2023 Apr 29;13:7046. doi: 10.1038/s41598-023-33002-8

Table 3.

Differentially methylated regions (DMRs) associated with phthalate concentration variables.

Chr Start End N Estimate SE p-value Adjusted p-value Overlapping gene
Maternal urine MEOHP, late pregnancy
Chr16 5,666,398 5,666,499 2  − 0.1247 0.0272 4.7E-06 9.5E-03 RP11-420N3.2
Chr12 94,579,928 94,580,329 2 0.0799 0.0181 1.1E-05 2.2E-02 PLXNC1
Chr20 36,259,574 36,259,855 3 0.0922 0.0213 1.5E-05 3.1E-02
Chr20 4,942,894 4,943,173 2 0.1236 0.0292 2.4E-05 4.9E-02 SLC23A2
Chr9 131,682,859 131,683,132 3  − 0.0650 0.0154 2.4E-05 4.9E-02
Urine MEOHP at birth
Chr16 67,999,044 67,999,055 2  − 0.2301 0.0479 1.6E-06 5.9E-03 SLC12A4
Chr11 65,357,780 65,358,078 2  − 0.2406 0.0503 1.7E-06 6.6E-03 EHBP1L1
Chr14 36,946,996 36,947,368 2 0.2105 0.0444 2.2E-06 8.2E-03 RP11-896J10.3;SFTA3
Chr17 7,493,572 7,494,095 4  − 0.1844 0.0401 4.3E-06 1.6E-02 MPDU1
Chr19 39,806,522 39,807,167 3  − 0.1748 0.0381 4.4E-06 1.7E-02 CTC-246B18.8
Chr1 162,530,191 162,530,364 2  − 0.2238 0.0491 5.3E-06 2.0E-02 TBC1D7
Chr6 13,295,922 13,295,976 3  − 0.2343 0.0515 5.4E-06 2.0E-02 RP11-359K18.3
Chr3 157,807,441 157,807,694 2 0.2384 0.0529 6.7E-06 2.5E-02
Chr19 44,952,808 44,953,124 2  − 0.2087 0.0464 6.8E-06 2.6E-02
Chr14 70,883,847 70,884,510 8  − 0.1323 0.0296 8.1E-06 3.1E-02
Chr10 1,438,165 1,438,548 2  − 0.2264 0.0508 8.2E-06 3.1E-02 ADARB2
Chr15 40,630,371 40,630,791 2  − 0.1821 0.0414 1.1E-05 4.2E-02 C15orf52
Chr6 31,760,426 31,760,593 2  − 0.2210 0.0504 1.2E-05 4.4E-02 VARS
Maternal urine MEHHP, late pregnancy
Chr3 69,249,276 69,249,718 2 0.0547 0.0120 4.8E-06 9.5E-03 FRMD4B
Chr8 6,481,582 6,481,608 2  − 0.1298 0.0289 7.1E-06 1.4E-02 MCPH1;CTD-2541M15.1
Chr16 5,666,398 5,666,499 2  − 0.1133 0.0258 1.1E-05 2.2E-02 RP11-420N3.2
Chr12 94,579,928 94,580,329 2 0.0751 0.0172 1.2E-05 2.4E-02 PLXNC1
Chr9 131,682,737 131,683,044 3  − 0.0630 0.0145 1.5E-05 2.9E-02
Urine MEHHP at birth
Chr16 67,999,044 67,999,055 2  − 0.2258 0.0469 1.5E-06 3.5E-03 SLC12A4
Chr19 39,806,522 39,807,167 3  − 0.1744 0.0369 2.3E-06 5.5E-03 CTC-246B18.8
Chr11 65,357,780 65,358,078 2  − 0.2309 0.0493 2.8E-06 6.5E-03 EHBP1L1
Chr13 39,358,777 39,358,795 2  − 0.2349 0.0512 4.4E-06 1.0E-02 FREM2
Chr14 36,946,996 36,947,368 2 0.1932 0.0436 9.6E-06 2.2E-02 RP11-896J10.3;SFTA3
Chr14 70,883,847 70,884,204 5  − 0.1434 0.0324 9.6E-06 2.2E-02
Chr19 44,952,808 44,953,124 2  − 0.1982 0.0449 1.0E-05 2.3E-02
Chr1 200,841,769 200,841,805 2  − 0.2098 0.0478 1.2E-05 2.7E-02
Chr9 136,200,708 136,201,061 2  − 0.1863 0.0432 1.6E-05 3.8E-02 SURF6
Chr7 158,613,567 158,614,019 2  − 0.2341 0.0544 1.7E-05 4.0E-02 ESYT2
Chr12 4,918,169 4,919,230 10 0.1982 0.0464 1.9E-05 4.5E-02 GALNT8;KCNA6
Maternal urine MnBP, late pregnancy
Chr9 131,682,737 131,683,132 4  − 0.0546 0.0106 2.4E-07 1.2E-03
Chr12 133,406,047 133,406,309 2  − 0.0458 0.0096 1.8E-06 9.0E-03 CHFR
Chr15 34,394,035 34,394,207 3  − 0.0866 0.0188 4.3E-06 1.6E-02 EMC7
Chr16 30,816,719 30,816,924 2  − 0.0765 0.0169 5.9E-06 9.2E-02
Chr6 170,038,695 170,038,733 2 0.0825 0.0184 7.5E-06 3.7E-02 WDR27
Chr10 7,708,869 7,708,934 2  − 0.0822 0.0186 9.5E-06 4.7E-02 ITIH5
Urine MnBP at birth
Chr4 1,363,008 1,363,182 2  − 0.1577 0.0311 3.9E-07 2.1E-03 UVSSA
Chr19 39,806,522 39,807,167 3  − 0.1335 0.0284 2.6E-06 1.4E-02 CTC-246B18.8
Chr6 32,406,271 32,406,521 2  − 0.1922 0.0412 3.1E-06 1.7E-02
Chr10 132,887,109 132,887,552 2  − 0.1635 0.0356 4.5E-06 2.4E-02
Chr15 55,489,541 55,489,544 2  − 0.1905 0.0425 7.3E-06 3.9E-02
Maternal urine DEHP, late pregnancy
Chr16 5,666,398 5,666,499 2  − 0.1219 0.0268 5.6E-06 1.1E-02 RP11-420N3.2
Chr12 94,579,928 94,580,329 2 0.0782 0.0179 1.2E-05 2.5E-02 PLXNC1
Chr8 6,481,582 6,481,608 2  − 0.1316 0.0302 1.3E-05 2.7E-02 MCPH1; CTD-2541M15.1
Chr3 69,249,276 69,249,718 2 0.0542 0.0125 1.4E-05 2.7E-02 FRMD4B
Chr9 131,682,737 131,683,044 3  − 0.0659 0.0151 1.4E-05 2.7E-02
Chr20 36,259,574 36,259,855 3 0.0885 0.0210 2.5E-05 5.0E-02
Urine DEHP at birth
Chr16 67,999,044 67,999,055 2  − 0.2365 0.0482 9.3E-07 3.0E-03 SLC12A4
Chr11 65,357,780 65,358,078 2  − 0.2458 0.0507 1.2E-06 3.9E-03 EHBP1L1
Chr19 39,806,522 39,807,167 3  − 0.1808 0.0381 2.1E-06 6.9E-03 CTC-246B18.8
Chr14 36,946,996 36,947,368 2 0.2112 0.0447 2.3E-06 7.3E-03 RP11-896J10.3; SFTA3
Chr17 7,493,572 7,494,095 4  − 0.1824 0.0405 6.5E-06 2.1E-02 MPDU1
Chr14 70,883,847 70,884,510 8  − 0.1339 0.0297 6.6E-06 2.1E-02
Chr19 44,952,808 44,953,124 2  − 0.2084 0.0464 7.1E-06 2.3E-02
Chr6 13,295,922 13,295,976 3  − 0.2323 0.0519 7.5E-06 2.4E-02 TBC1D7
Chr6 31,760,426 31,760,593 2  − 0.2249 0.0505 8.5E-06 2.7E-02 VARS
Chr1 162,530,191 162,530,364 2  − 0.2192 0.0496 9.7E-06 3.1E-02 RP11-359K18.3
Chr10 1,438,165 1,438,548 2  − 0.2246 0.0509 1.0E-05 3.3E-02 ADARB2
Chr16 1,824,041 1,824,177 2  − 0.2453 0.0565 1.4E-05 4.5E-02 EME2
Chr1 200,841,769 200,841,805 2  − 0.2149 0.0496 1.5E-05 4.7E-02

n: number of CpGs; SE: standard error.